Related Experiment Videos
Serial ECG measurements at controlled plasma levels of nortriptyline in depressed children
The American Journal of Psychiatry
|September 1, 1985
Insights
Nortriptyline treatment for pediatric major depressive disorder did not significantly alter electrocardiogram (ECG) measurements. Cardiac safety was maintained in children receiving nortriptyline within the specified plasma concentration range.
Area of Science:
- Pediatric Cardiology
- Psychopharmacology
- Clinical Electrocardiography
Background:
- Major depressive disorder (MDD) is a prevalent mental health condition in children.
- Nortriptyline is a tricyclic antidepressant used in pediatric MDD treatment.
- Electrocardiogram (ECG) monitoring is crucial for assessing cardiac safety during antidepressant therapy.
Purpose of the Study:
- To evaluate the effects of nortriptyline on ECG parameters in children with MDD.
- To determine if cardiac intervals and heart rate remain within normal limits during nortriptyline treatment.
Main Methods:
- Prospective study involving 21 children diagnosed with MDD.
- ECG measurements (P-R interval, QRS duration, heart rate) were recorded at baseline and weekly during nortriptyline treatment.
- Nortriptyline plasma levels were maintained between 50-100 ng/ml.
Main Results:
- All measured ECG parameters (P-R interval, QRS duration, heart rate) remained within established clinical guidelines throughout the study period.
- No significant adverse cardiac events related to nortriptyline were observed.
Conclusions:
- Nortriptyline treatment at plasma levels of 50-100 ng/ml appears to be safe concerning cardiac function in children with MDD.
- Routine ECG monitoring confirmed the absence of clinically significant cardiac changes during nortriptyline therapy in this pediatric cohort.
Abstract:
The authors investigated ECG measurements in 21 children with major depressive disorder treated with nortriptyline at plasma levels of 50-100 ng/ml. P-R and QRS intervals and heart rate measured at baseline and once a week during treatment remained within guidelines.